Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
Yongqiang Liu(Institute of Zoology), Guang‐Biao Zhou(Institute of Zoology)
Cited by 65
Related Papers
Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
|Carcinogenesis|2013|105
Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma
|PLoS ONE|2011|49